IL134087A0 - Composition, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches - Google Patents

Composition, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches

Info

Publication number
IL134087A0
IL134087A0 IL13408798A IL13408798A IL134087A0 IL 134087 A0 IL134087 A0 IL 134087A0 IL 13408798 A IL13408798 A IL 13408798A IL 13408798 A IL13408798 A IL 13408798A IL 134087 A0 IL134087 A0 IL 134087A0
Authority
IL
Israel
Prior art keywords
kits
composition
methods
neurovascular disorders
cerebral neurovascular
Prior art date
Application number
IL13408798A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL134087A0 publication Critical patent/IL134087A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13408798A 1997-07-21 1998-07-17 Composition, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches IL134087A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89719297A 1997-07-21 1997-07-21
US7284598P 1998-01-28 1998-01-28
US8455998P 1998-05-06 1998-05-06
PCT/US1998/014870 WO1999003473A1 (en) 1997-07-21 1998-07-17 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches

Publications (1)

Publication Number Publication Date
IL134087A0 true IL134087A0 (en) 2001-04-30

Family

ID=27372174

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13408798A IL134087A0 (en) 1997-07-21 1998-07-17 Composition, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
IL134087A IL134087A (en) 1997-07-21 2000-01-17 Use of local anesthesia for the preparation of a preparation for the treatment of muscular headaches and neurovascular brain disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL134087A IL134087A (en) 1997-07-21 2000-01-17 Use of local anesthesia for the preparation of a preparation for the treatment of muscular headaches and neurovascular brain disorders

Country Status (20)

Country Link
EP (1) EP0999839B1 (de)
JP (1) JP4521117B2 (de)
KR (1) KR20010022041A (de)
CN (1) CN1267219A (de)
AR (1) AR013240A1 (de)
AT (1) ATE269702T1 (de)
AU (1) AU8574398A (de)
BR (1) BR9810773A (de)
CA (1) CA2297097C (de)
DE (1) DE69824730T2 (de)
EE (1) EE200000050A (de)
HU (1) HUP0003953A3 (de)
ID (1) ID24903A (de)
IL (2) IL134087A0 (de)
IS (1) IS5349A (de)
NO (1) NO20000293L (de)
PL (1) PL338176A1 (de)
SK (1) SK187899A3 (de)
TR (1) TR200000149T2 (de)
WO (1) WO1999003473A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
JP4632499B2 (ja) * 1999-08-26 2011-02-16 武田薬品工業株式会社 鼻粘膜付着マトリックス
WO2001043733A2 (en) * 1999-12-15 2001-06-21 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US6853858B2 (en) 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
WO2005062829A2 (en) 2003-12-19 2005-07-14 Advanced Bionics Corporation Skull-mounted electrical stimulation system and method for treating patients
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
EP1782831B1 (de) 2004-08-18 2011-10-19 Medrx Co., Ltd. Topisches präparat
MX2011000862A (es) * 2008-07-21 2011-03-15 Otonomy Inc Composiciones antimicrobianas de liberacion controlada y metodos para el tratamiento de trastornos oticos.
DE102008037682A1 (de) 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
NZ629475A (en) 2012-09-28 2017-03-31 St Renatus Llc Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
CN103432378A (zh) * 2013-08-15 2013-12-11 吕清华 一种治疗神经血管性头痛的中药
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3914246A1 (de) * 2019-01-22 2021-12-01 ICM (Institut du Cerveau et de la Moelle Épinière) Lokalanästhetikum zur behandlung von neurologischen symptomen infolge von hirnfunktionsstörungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
DE19524691A1 (de) * 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
DE19526019A1 (de) * 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Kopfschmerzen
BE1009851A3 (fr) * 1996-01-11 1997-10-07 Thiebauld Charles Marie Composition pharmaceutique pour le traitement des cephalees et son utilisation.
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use

Also Published As

Publication number Publication date
JP4521117B2 (ja) 2010-08-11
ID24903A (id) 2000-08-31
JP2001513483A (ja) 2001-09-04
KR20010022041A (ko) 2001-03-15
AR013240A1 (es) 2000-12-13
CA2297097C (en) 2009-04-07
TR200000149T2 (tr) 2000-05-22
BR9810773A (pt) 2000-09-19
EP0999839A1 (de) 2000-05-17
HUP0003953A1 (hu) 2002-01-28
IS5349A (is) 2000-01-18
AU8574398A (en) 1999-02-10
NO20000293D0 (no) 2000-01-20
PL338176A1 (en) 2000-10-09
ATE269702T1 (de) 2004-07-15
CA2297097A1 (en) 1999-01-28
CN1267219A (zh) 2000-09-20
DE69824730D1 (de) 2004-07-29
SK187899A3 (en) 2000-12-11
IL134087A (en) 2006-10-31
EE200000050A (et) 2000-10-16
EP0999839B1 (de) 2004-06-23
WO1999003473A1 (en) 1999-01-28
DE69824730T2 (de) 2005-07-14
HUP0003953A3 (en) 2002-02-28
NO20000293L (no) 2000-03-20

Similar Documents

Publication Publication Date Title
AU2862200A (en) Compositions, kits, apparatus, and methods for inhibiting cerebral neurovasculardisorders and muscular headaches
IL134087A0 (en) Composition, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
HUP0003964A2 (en) Methods for treating thrombotic disorders
AU2001285159A1 (en) Methods for treating endocrine disorders
GB9621828D0 (en) Impact analysers for golf
HK1018272A1 (en) Substituted pyridylmethylpiperazine and piperidinederivatives, their preparation and their use for treating central nervous system (cns) disorders
HK1042999B (zh) 波分復用信道均衡器
GB2335026B (en) Dephlegmator
AU2001236737A1 (en) Method of reducing aluminum levels in the central nervous system
EP1064295A4 (de) Verfahren und zusammensetzungen zur diagnose und behandlung von störungen die auf chromosom 18p beruhen
AU2001257129A1 (en) Novel pharmacotherapeutic process and composition for central nervous system disorders
EP0679397A3 (de) Verwendung von substituierten Aminen zur Behandlung von Hirnleistungsstörungen.
AU4239597A (en) Novel pharmacotherapeutic process and composition for central nervous system disorders
ZA986449B (en) Compositions kits and methods for inhibiting cerebral neurovascular disorders and muscular headaches
GB9807359D0 (en) Saddle cork pad
HUP0103106A3 (en) Method for producing 4,6-disubstituted 2-isocyanatopyrimidines and their use as intermediate
LTIP2000A (en) Composition for bitter alkoholic beverage
AU9106198A (en) Methods for inhibiting temporomandibular disorders
AU2001295689A1 (en) Compositions and methods for regulating the nervous system
ZA987390B (en) Methods for preventing headaches.
AU2003204221A1 (en) Dipyridoimidazolderivatives useful in treating central nervous system disorders
IL154239A0 (en) Methods and compositions for diagnosing and treating chromosome-18p related disorders
IL116922A0 (en) Compositions for the regeneration of nerves in the central nervous system
GB9620972D0 (en) Fixings for swing seats
GB9603333D0 (en) Tee-line golf alignment set-up aid

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed